Navigating an executive leadership change? Use our eBook to facilitate a smooth transition. Download Now

Westicke Partners

Close

Westwicke Blog

The Westwicke Blog is designed to deliver information and insights into the ever-changing world of healthcare communications.

The Evolution of SPACs: New Challenges and Opportunities

Posted on May 20th, 2021. Posted by

Evolution of SPAC

Special purpose acquisition company (SPAC) activity has exploded in the past two years, from 59 transactions in 2019, to 248 deals in 2020, to 308 SPACs so far in 2021. However, SPACs are not new. This type of transaction has been around for decades, continually evolving as it rises and falls in popularity.

Continue Reading

What to Know About Going Public Through an IPO, SPAC, or Direct Listing

Posted on May 6th, 2021. Posted by

Going Public: IPO, SPAC, or Direct Listing?

Going public is a transformational event that gives companies the capital they need to invest in future growth, attract top talent, and raise their profile, while providing liquidity to investors and employees.

Continue Reading

Panel Discussion and Highlights from the Westwicke / ICR Conference 2021

Posted on January 27th, 2021. Posted by

Westwicke ICR Conference 2021

The 2021 Westwicke / ICR Conference went virtual this year — and like many in-person events suddenly turned remote, attendees found new and unexpected opportunities for connecting with each other. Namely, the ability, finally, to be in two meetings at once.

Continue Reading

Direct Listings: A Communicator’s Guide

Posted on November 11th, 2020. Posted by

Direct Listings: A Communicator’s Guide

After a long period of market uncertainty driven by the COVID-19 pandemic, the second half of 2020 saw market conditions improve for IPOs with a recent flurry of tech companies making their debut. With increased demand to access the public markets, a strong pipeline of companies set to come to market is shaping up quickly for all of 2021.

Continue Reading

2020 Gives Rise to Another IPO Alternative: Direct Listings

Posted on October 30th, 2020. Posted by

Wall Street - Direct Listings

In the wake of the coronavirus pandemic, the IPO market may never look the same. The swift shift to virtual roadshows, for example, has demonstrated efficiencies that are likely to make digital alternatives stick even after regular business travel resumes. But beyond the operational changes behind preparing a company to go public, the market has seen growing interest in alternatives to the IPO itself.

Continue Reading

How to Make the Most of Virtual Non-Deal Roadshows

Posted on October 8th, 2020. Posted by

Virtual Non-Deal Roadshows

The challenges of functioning successfully in an extended COVID-19 environment have presented many new ways of doing business. This is especially evident for events such as non-deal roadshows (NDRs).

Continue Reading

Things to Know About SPAC Transactions

Posted on September 25th, 2020. Posted by

Info About SPAC Transactions

Over the past several months, interest in special purpose acquisition companies (SPACs) has grown exponentially. SPAC transactions serve as an alternative to traditional IPOs, and while they have existed for many years, they are currently experiencing a resurgence within several industries.

Continue Reading

The Virtual IPO: How IPOs Are Changing

Posted on August 26th, 2020. Posted by

Expert Advice on IPOs

According to some experts, the past several months have created more change in the IPO market than the last 25 to 30 years. In the recent webinar hosted by ICR Capital and Davis Polk, those experts discussed what they’ve seen in the IPO market recently, changes to standard IPO processes, and what’s to come for IPOs during the remainder of the year.

Continue Reading

Biotech IPOs: What to Expect in the Second Half of 2020

Posted on August 6th, 2020. Posted by

Biotech IPOs

For much of the first half of 2020, the coronavirus pandemic ground most business to a halt. Biotech innovation, however, has continued in full force. Even during the turbulent first few months of the year, biotech companies have moved forward with successful IPOs.

The pandemic isn’t over, however, and cases continue to rise in parts of the U.S. What will that mean for IPOs in the second half of the year?

Continue Reading

Should You Proceed With IPO Planning Regardless of Market Conditions?

Posted on April 22nd, 2020. Posted by and

Should You Proceed With IPO Planning Regardless of Market Conditions?

In January, we made three predictions about the IPO market in 2020 — but no one could have predicted the current market conditions and business ramifications as a result of the coronavirus pandemic. Companies across the globe have had to change the way they do business, from transitioning to a remote workforce to making changes to their supply chain.

Continue Reading

1 2 3 7

Preparing for an investor meeting?

Download our checklist of 6 questions investors will ask to make a decision about your company.

Our Locations